Cited by 1,007Mitochondrial Function and PathologyMetabolism, Diabetes, and CancerAdvanced Glycation End Products research

Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress

Open access
Rolo, Anabela P., Palmeira, Carlos M.·2006·Toxicology and Applied Pharmacology

Abstract

Hyperglycemia resulting from uncontrolled glucose regulation is widely recognized as the causal link between diabetes and diabetic complications. Four major molecular mechanisms have been implicated in hyperglycemia-induced tissue damage: activation of protein kinase C (PKC) isoforms via de novo synthesis of the lipid second messenger diacylglycerol (DAG), increased hexosamine pathway flux, increased advanced glycation end product (AGE) formation, and increased polyol pathway flux. Hyperglycemia-induced overproduction of superoxide is the causal link between high glucose and the pathways responsible for hyperglycemic damage. In fact, diabetes is typically accompanied by increased production of free radicals and/or impaired antioxidant defense capabilities, indicating a central contribution for reactive oxygen species (ROS) in the onset, progression, and pathological consequences of diabetes. Besides oxidative stress, a growing body of evidence has demonstrated a link between various disturbances in mitochondrial functioning and type 2 diabetes. Mutations in mitochondrial DNA (mtDNA) and decreases in mtDNA copy number have been linked to the pathogenesis of type 2 diabetes. The study of the relationship of mtDNA to type 2 diabetes has revealed the influence of the mitochondria on nuclear-encoded glucose transporters, glucose-stimulated insulin secretion, and nuclear-encoded uncoupling proteins (UCPs) in beta-cell glucose toxicity. This review focuses on a range of mitochondrial factors important in the pathogenesis of diabetes. We review the published literature regarding the direct effects of hyperglycemia on mitochondrial function and suggest the possibility of regulation of mitochondrial function at a transcriptional level in response to hyperglycemia. The main goal of this review is to include a fresh consideration of pathways involved in hyperglycemia-induced diabetic complications.

Integrity signals

Registry

Crossref · 10.1016/j.taap.2006.01.003

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Studies assessing mitochondrial copy number in skeletal muscle in insulin-resistant individuals have reported conflicting results.

    “Thus, studies which have assessed mitochondrial copy number in skeletal muscle in insulin-resistant individuals have reported conflicting results [114–116].”

    From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [114]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rolo, A. P., & Palmeira, C. M.
Affiliations
Centro de Neurociências e Biologia Celular (PT)
Corresponding author
Palmeira, Carlos M.
Venue
Toxicology and Applied Pharmacology
Publisher
Elsevier BV
Published
2006-04
Volume
212
Issue
2
Pages
167-178
ISSN
0041-008X (ISSN-L)
OpenAlex
W1966621383
Cited by
1,007
References
115
Citations by year
2026: 21 · 2025: 35 · 2024: 43 · 2023: 36 · 2022: 42 · 2021: 58 · 2020: 57 · 2019: 44 · 2018: 65 · 2017: 48 · 2016: 59 · 2015: 70 · 2014: 65 · 2013: 64 · 2012: 60
FWCI
3.24
Type
journal article
Language
en
Open access
Locations
  • Toxicology and Applied Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Keywords
diabetes mellitus, hyperglycemia, mitochondrial function, oxidative stress, type 2 diabetes, protein kinase C, diacylglycerol, hexosamine biosynthetic pathway, advanced glycation end products, polyol pathway, superoxide, reactive oxygen species, mitochondrial DNA mutations, mitochondrial DNA copy number, glucose transporters, glucose-stimulated insulin secretion, uncoupling proteins, diabetes complications
MeSH terms
Animals, Diabetes Mellitus, Gene Expression Regulation, Glucose, Humans, Hyperglycemia, Hypoglycemic Agents, Insulin, Mitochondria, Uncoupling Agents, Oxidative Stress, Insulin-Secreting Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review